Nicole Verdun - Concepedia

Author

Nicole Verdun

United States Food and Drug Administration

Also Known As

N. Verdun, Nicole C. Verdun, Nicole Verdun

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Biologics Evaluation and Research Johns Hopkins University Mayo Clinic in Florida Mayo Clinic

About

Nicole Verdun is an author at United States Food and Drug Administration specializing in medicine, health sciences, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	525
2	Health Sciences	4	4	475
3	Public Health	2	2	50
4	Epidemiology	2	2	50
5	Diagnostic Sciences	1	1	237

Nicole Verdun

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld, New England Journal of Medicine	2021	539
Early safety indicators of COVID-19 convalescent plasma in 5000 patients Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Journal of Clinical Investigation	2020	478
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy Nicole Verdun, Peter Marks New England Journal of Medicine ImmunologyPathologySecondary CancersCar-t ProductsImmunotherapy	2024	237
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia R. Angelo de Claro, Karen M. McGinn, Nicole Verdun, Clinical Cancer Research Preclinical TherapeuticsTyrosine KinasePathologyFda ApprovalPharmacotherapy	2015	156
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings Neil A. Goldenberg, Thomas C. Abshire, Patrick J. Blatchford, Journal of Thrombosis and Haemostasis ThrombosisYoung AdultsVenous ThrombosisCardiovascular DiseasePediatric Hematology	2015	66
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study Jonathon W. Senefeld, Patrick W. Johnson, Katie L. Kunze, PLoS Medicine	2021	65
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma Hyung Park, Thaddeus Tarpey, Mengling Liu, JAMA Network Open	2022	65
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors Katie L. Kunze, Patrick W. Johnson, Noud van Helmond, Nature Communications	2021	59
Challenges and Priorities for Research Brian W. McCrindle, Jennifer S. Li, Cedric Manlhiot, Circulation Research-practice PartnershipScience And Technology StudiesResearch EthicsResearch DesignProblem Importance	2014	33
Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting. Dragoslav Domanović, Ines Ushiro‐Lumb, Veerle Compernolle, PubMed Point-of-care TestingDisease OutbreakInfectious Disease ControlPathogen ReductionPathogen Epidemiology	2019	29

Page 1